News & Updates

Treatment with corticosteroids (CS) among children with multisystem inflammatory syndrome (MIS-C) cardiovascular involvement temporarily associated with COVID-19 leads to faster normalization of left ventricular ejection fraction (LVEF), fever, improved laboratory analysis, and shorter intensive care unit stay than treatment with intravenous immunoglobulin (IVIG), a study has shown.

The oral selective Janus kinase 1/2 inhibitor baricitinib, when added to standard of care (SoC), reduced the risk of mortality among adults hospitalized with COVID-19. However, the primary outcome of disease progression was not met in the baricitinib group, results of the phase III COV-BARRIER study showed.

Treatment with calcifediol shortly after hospitalization with COVID-19 results in a significant reduction in intensive care unit (ICU) admission and death by more than 50 percent, reveals a study. In addition, baseline 25(OH)D levels is negatively associated with both ICU admission and mortality.

Smartwatches, with the support of machine learning algorithms, can perceive face-touching (FT) behaviours and may help contain outbreaks of respiratory infections such as the coronavirus disease 2019 (COVID-19), according to a new study.

A large retrospective study from the US, presented at IDWeek 2021, has shown that the Abbott ID NOW rapid molecular COVID-19 assay is highly sensitive and specific at detecting SARS-CoV-2 infection in a paediatric population.

Patients coinfected with the coronavirus disease 2019 (COVID-19) and Chagas disease are more likely to have cardiovascular comorbidities, but do not seem to suffer from worse in-hospital outcomes, a recent study has found.

Data presented at ID Week 2021 show that Clostridioides difficile (CDI), which is known to be hospital-associated, is highly prevalent even in nonhealthcare settings.